Mounjaro denied by insurance — how to appeal

About Mounjaro

Mounjaro denials follow patterns similar to Ozempic — most are prior-authorization issues that can be resolved by supplying the missing documentation in a structured appeal. The strongest appeals attach the HbA1c history, the documented prior-treatment record, and a treating-provider letter that explains why Mounjaro is the appropriate next step.

Common reasons Mounjaro gets denied

• Prior authorization not in place
• Step therapy not completed
• Diagnosis code does not match approved indication
• Pharmacy benefit excludes the drug class

Evidence that helps overturn a Mounjaro denial

• Provider letter with diagnosis and treatment history
• HbA1c history
• Documentation of prior treatments tried and outcomes
• FDA labeling for type 2 diabetes

Recommended approach

For most Mounjaro denials, our triage will recommend the Premium Appeal ($499) tier. We prepare a professionally-structured appeal that addresses the specific denial reason, cites the relevant clinical evidence, and meets your insurer’s appeal-rights deadlines. Treatment cost exposure: typically $1,000–$1,200 per month.

What to do next

1. Find your denial letter (or EOB) and check the appeal deadline.
2. Upload it to InsureDefense for a free triage — no payment required to see the assessment.
3. If you choose to proceed, you’ll receive a draft within 24 hours (12 hours for urgent cases).
4. Submit the appeal to your insurer using the fax / portal / mailing address we provide.
5. Track the insurer’s response using our 14/30/45-day follow-up reminders.

Upload your Mounjaro denial See pricing